Pseudomonas aeruginosa global clones associated with multidrug-resistant (MDR) and
extensively drug-resistant (XDR) phenotypes, denominated high-risk clones, are a growing …

Modern medicine is threatened by the rising tide of antimicrobial resistance, especially
among Gram-negative bacteria, where resistance to β-lactams is most often mediated by β …

Background ESBL-and carbapenemase-producing Pseudomonas aeruginosa are prevalent
in, for example, the Middle East, Eastern Europe and Latin America, though rarer elsewhere …

Objectives: To identify the carbapenemase producing Gram-negative bacteria (GNB) by
phenotypic methods and to confirm the presence of resistant genes using real-time …

We describe a case of New Delhi metallo-β-lactamase 1–producing carbapenem-resistant
Pseudomonas aeruginosa (CRPA) in a transplant patient with multiple hospitalizations in …

Genotyping of 2,882 Pseudomonas aeruginosa isolates that had been collected during the
last 40 years identified the ExoU-positive lineages PA14 (ST253) and ST235 as the second …

Antibiotics like colistin can save patients infected with carbapenem-resistant Pseudomonas
aeruginosa. However, patients can succumb to such infections even if they undergo colistin …

Carbapenem-resistant Pseudomonas aeruginosa is defined by the World Health
Organization as a" high priority" in developing new antimicrobials. Indeed, the emergence …

Pseudomonas aeruginosa (PA) is one of the major factors in severe opportunistic and
hospital-acquired infections. Structural mechanisms such as resistance–nodulation–division …

The population structure of Pseudomonas aeruginosa is panmictic-epidemic in nature, with
the prevalence of some high-risk clones. These clones are often linked to virulence …